Emily and Joey Spadafore watched helplessly as their 3-month-old son, Benjamin, battled RSV for a week in the hospital.

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

Emily and Joey Spadafore watched helplessly as their 3-month-old son, Benjamin, battled RSV for a week in the hospital.

this will help protect your baby for the first few months after they're born you are aged 75 to 79 The vaccine helps reduce the risk of RSV causing serious problems such as pneumonia and ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled ...

Respiratory syncytial virus (RSV), or human respiratory syncytial virus (hRSV), is a common viral respiratory infection that triggers mild, cold-like symptoms. However, at-risk populations ...

Recent studies reveal a new version of the immunization is combating the virus at a highly effective pace, and UVMMC is seeing that directly with low hospitalizations for the virus. RSV is ...

But with COVID-19, the flu, respiratory syncytial virus, or RSV, and just the common cold all floating around and all sharing several similar symptoms, how are you supposed to know what you might ...

The surge in flu cases also comes amid concerns about high infection rates for other viruses including RSV, COVID-19 and the gastrointestinal bug norovirus. Still, health officials say flu cases ...

Canada’s colder weather goes hand-in-hand with respiratory virus season, with flu, RSV and COVID-19 circulating. While Canadians learned a lot about how to protect themselves from illness during ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...